SCHEMBL8501896

SCHEMBL8501896

O=C(c1ccc(Cl)cc1)c1c(Cl)ccc(Cc2ccn[nH]c2=O)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTT P42858 3/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ ALOX15 P16050 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CYP19A1 P11511 1/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ SRD5A2 P31213 1/20 0.33
▸ NR4A1 P22736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8503196 0.83 MEN1 (0.41) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL8504731 0.78 HPGDS (0.35) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL8502519 0.74 MRGPRX4 (0.36) MEN1KMT2AHTTALDH1A1ALOX15
SCHEMBL8502116 0.74 MEN1 (0.38) MEN1KMT2AHTTALDH1A1ALOX15
SCHEMBL8506458 0.73 MRGPRX4 (0.37) MEN1KMT2AHTTALDH1A1ALOX15
SCHEMBL8502108 0.72 KMT2A (0.39) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL8504856 0.71 ALDH1A1 (0.47) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL8505814 0.71 ADRB2 (0.42) RAB9AMEN1KMT2AHTTALDH1A1
SCHEMBL8503702 0.69 IL4I1 (0.37) POLB
SCHEMBL8501895 0.68 HTT (0.40) RAB9AMEN1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886178-A ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1999-03-23 — — US disclosed
Send feedback